Audentes Therapeutics, Inc.

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Chad Diehl, Attorney-in-Fact, Astellas
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Audentes Therapeutics, Inc.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Taysha Gene Therapies, Inc. 10%+ Owner Common Stock 7,266,342 $11,844,137 $1.63 21 Oct 2022 Direct

Insider Reports Filed by Audentes Therapeutics, Inc.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TSHA Taysha Gene Therapies, Inc. 21 Oct 2022 0 $0 3 10%+ Owner 31 Oct 2022, 16:05